Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *


ATC
ATC Description

ATC

ATC Code ATC Description
L01EE06 L01EE06 Tunlametinib
L01EF L01EF Cyclin-dependent kinase (CDK) inhibitors
L01EF01 L01EF01 Palbociclib
L01EF02 L01EF02 Ribociclib
L01EF03 L01EF03 Abemaciclib
L01EG L01EG Mammalian target of rapamycin (mTOR) kinase inhibitors
L01EG01 L01EG01 Temsirolimus
L01EG02 L01EG02 Everolimus
L01EH L01EH Human epidermal growth factor receptor 2 (HER2) tyrosine kinase inhibitors
L01EH01 L01EH01 Lapatinib
L01EH02 L01EH02 Neratinib
L01EH03 L01EH03 Tucatinib
L01EH04 L01EH04 Zongertinib
L01EH05 L01EH05 Mifanertinib
L01EH06 L01EH06 Sevabertinib
L01EJ Janus-associated kinase (JAK) inhibitors
L01EJ01 L01EJ01 Ruxolitinib
L01EJ02 L01EJ02 Fedratinib
L01EJ03 L01EJ03 Pacritinib
L01EJ04 L01EJ04 Momelotinib
L01EL L01EL Bruton's tyrosine kinase (BTK) inhibitors
L01EL01 L01EL01 Ibrutinib
L01EL02 L01EL02 Acalabrutinib
L01EL03 L01EL03 Zanubrutinib
L01EL04 L01EL04 Orelabrutinib
L01EL05 L01EL05 Pirtobrutinib
L01EL06 L01EL06 Tirabrutinib
L01EM L01EM Phosphatidylinositol-3-kinase (PI3K) inhibitors
L01EM01 L01EM01 Idelalisib
L01EM02 L01EM02 Copanlisib
Showing 30 of 7196 Records